Unosi

• Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression. (2021)

  J. Berendika, S. Jungić, B. Tubić, G. Kecman, I. Rakita, Z. Gojković, M. Vještica, G. Nikić, B. Babić, Adjuvant Treatment of the Salivary Duct Carcinoma with Her2 Overexpression., Case reports in oncology , pp. 610 - 615, 2021

• Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: single-center study (2022)

  S. Jungić, B. Tubić, J. Berendika, I. Rakita, M. Vjestica, R. Gajanin, Optimal duration of therapy in the first line treatment of metastatic colorectal cancer: single-center study, VOJNOSANITETSKI PREGLED, Vol. 79, No. 8, pp. 796 - 804, 2022

• A case report of malignant peripheral nerve sheath tumour of the left thigh and popliteal fossa with lungs, spleen, and brain dissemination related to neurofibromatosis type 1. (2022-06)

  S. Petković, S. Petković, Lj. Tadić-Latinović, B. Tubić, S. Jungić, J. Berendika, A case report of malignant peripheral nerve sheath tumour of the left thigh and popliteal fossa with lungs, spleen, and brain dissemination related to neurofibromatosis type 1., Scripta Medica, Vol. 53, No. 2, Jun, 2022

• PRIMJENA PEMBROLIZUMABA KOD PACIJENATA SA PLUĆNIM METASTAZAMA MELANOMA NAŠA ISKUSTVA (2022-06)

  R. Rašeta, M. Vještica, Z. Gojković, S. Jungić, J. Draganović, J. Berendika, I. Rakita, N. Mirčeta, G. Nikić, G. Marić, P. Dašić, PRIMJENA PEMBROLIZUMABA KOD PACIJENATA SA PLUĆNIM METASTAZAMA MELANOMA NAŠA ISKUSTVA, Časopis udruženja pulmologa Republike Srpske, pp. 105 - 114, Jun, 2022

• Risk-factors for locally advanced rectal cancer relapse after neoadjuvant chemoradiotherapy: A single center experience. (2023-11)

  D. Stupar, S. Jungić, Z. Gojković, J. Berendika, Ž. Janjičić, Risk-factors for locally advanced rectal cancer relapse after neoadjuvant chemoradiotherapy: A single center experience., Medicine, Vol. 102, No. 44, Nov, 2023